Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Merck
Boehringer Ingelheim
Medtronic
Dow

Last Updated: February 3, 2023

CLINICAL TRIALS PROFILE FOR METOPIRONE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Metopirone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00567814 ↗ A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction Completed Embera NeuroTherapeutics, Inc. N/A 2007-12-01 Subjects will be randomly assigned to receive either one of the two potential dose combinations of the study medications or placebo over 6 weeks. The study will include twice weekly visits to the research clinic for laboratory studies, safety assessments and urine drug screens. Subjects will also be questioned regarding drug craving and mood symptoms.
NCT01673087 ↗ Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures Completed University of Michigan Phase 1 2012-10-01 Cortisol is a stress hormone that can be measured in saliva. This has provided a convenient way to evaluate the biological impact of day-to-day stressors that people encounter as they go about their lives, since saliva is so easy to collect. However, the biological meaning of saliva cortisol measures has never been carefully examined. The goal of this study is to collect saliva from a large group of people as they go about their every-day lives, to measure their cortisol levels, and then study them in the laboratory where Investigators can learn more about how their stress response system (which produces cortisol) is really functioning. Investigators can then determine much more precisely what saliva cortisol levels really mean in terms of stress system biology. This will allow investigators to obtain much more useful information from the next decade of research on naturalistic stress and its biological impact using saliva cortisol measures, helping investigators to understand how stress undermines health and how to combat this effect.
NCT02297945 ↗ Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome Completed HRA Pharma Phase 3 2015-04-01 The purpose of this prospective, international phase III/IV study is to assess the efficacy and safety of metyrapone in patients with endogenous Cushing's syndrome during up to 36 weeks of treatment. The ability of metyrapone (250 mg capsules) to normalize urinary free cortisol (UFC) levels will be assessed during up to 36 weeks (9 months) of treatment.
NCT02856854 ↗ A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine Completed National Institute on Drug Abuse (NIDA) Phase 1 2016-07-01 EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, metyrapone (Metopirone®), and the benzodiazepine receptor agonist, oxazepam (original trade name Serax®; now marketed as oxazepam (generic) only). This Phase 1b cocaine interaction study is being conducted in order to assess the safety and PK of EMB-001 and cocaine in combination.
NCT02856854 ↗ A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine Completed Embera NeuroTherapeutics, Inc. Phase 1 2016-07-01 EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, metyrapone (Metopirone®), and the benzodiazepine receptor agonist, oxazepam (original trade name Serax®; now marketed as oxazepam (generic) only). This Phase 1b cocaine interaction study is being conducted in order to assess the safety and PK of EMB-001 and cocaine in combination.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Metopirone

Condition Name

Condition Name for Metopirone
Intervention Trials
Cocaine Use Disorder 2
Cocaine Addiction 1
Cocaine Dependence 1
Cushing's Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Metopirone
Intervention Trials
Tobacco Use Disorder 1
Disease 1
Syndrome 1
Cushing Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Metopirone

Trials by Country

Trials by Country for Metopirone
Location Trials
United States 8
Italy 2
Germany 1
Poland 1
Turkey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Metopirone
Location Trials
North Carolina 1
South Carolina 1
Pennsylvania 1
Florida 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Metopirone

Clinical Trial Phase

Clinical Trial Phase for Metopirone
Clinical Trial Phase Trials
Phase 3 1
Phase 2 1
Phase 1/Phase 2 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Metopirone
Clinical Trial Phase Trials
Completed 4
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Metopirone

Sponsor Name

Sponsor Name for Metopirone
Sponsor Trials
Embera NeuroTherapeutics, Inc. 4
National Institute on Drug Abuse (NIDA) 2
Foundation for a Smoke-Free World 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Metopirone
Sponsor Trials
Industry 6
Other 2
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
McKinsey
Baxter
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.